Abstract
The previous chapters have described what cancer genes are and how they are acquired. But what do cancer genes do? How does the inactivation of tumor suppressor genes and activation of proto-oncogenes cause proliferating cells to evolve into cancers? The answer to this question has been revealed by the functional analysis of the proteins encoded by cancer genes and their wild type counterparts.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Bakkenist CJ, Kastan MB (2004) Initiating cellular stress responses. Cell 118:9–17
Bensaad K, Vousden KH (2007) P53: new roles in metabolism. Trends Cell Biol 17:286–291
Berger S (2010) Keeping p53 in check: a high-stakes balancing act. Cell 142:17–19
Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365
Cohen P (2002) The origins of protein phosphorylation. Nat Cell Biol 4:E127–E130
Dang CV (2012) MYC on the path to cancer. Cell 149:22–35
Fish EN, Platanias LC (2014) Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes. Mol Cancer Res 12:1691–1703
Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973–2983
Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25:5220–5227
Hajra KM, Fearon ER (2002) Cadherin and catenin alterations in human cancer. Genes Chromosom Cancer 34:255–268
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Horn HF, Vousden KH (2007) Coping with stress: multiple ways to activate p53. Oncogene 26:1306–1316
Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316–323
Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1:179–186
Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293
Linding R et al (2007) Systematic discovery of in vivo phosphorylation networks. Cell 129:1415–1426
Losman J-A, Kaelin WG Jr (2013) What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev 27:836–852
Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580:2811–2820
Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483–1487
Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45–51
Raabe EH, Eberhart CG (2012) Methylome alterations “mark” new therapeutic opportunities in glioblastoma. Cancer Cell 22:417–418
Samuels Y, Ericson K (2006) Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18:77–82
Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954–2963
Scott JD, Pawson T (2000) Cell communication: the inside story. Sci Am 282:72–79
Sears RC (2004) The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3:1133–1137
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ (2000) Understanding Ras: ‘it ain’t over til it’s over’. Trends Cell Biol 10:147–154
Simpson L, Parsons R (2001) PTEN: life as a tumor suppressor. Exp Cell Res 264:29–41
Solomon DA, Kim JS, Jean W, Waldman T (2008) Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme. Cancer Res 68:8657–8660
Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6:909–923
Venkitaraman AR (2005) Medicine: aborting the birth of cancer. Nature 434:829–830
Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2:489–501
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789–799
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339:1546–1558
Vousden KH, Lane DP (2007) P53 in health and disease. Nat Rev Mol Cell Biol 8:275–283
Wiley HS (2014) Open questions: the disrupted circuitry of the cancer cell. BMC Biol 12:88
Zhao JJ, Roberts TM (2006) PI3 kinases in cancer: from oncogene artifact to leading cancer target. Sci STKE 2006:pe52
Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408:433–439
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Bunz, F. (2016). Cancer Gene Pathways. In: Principles of Cancer Genetics. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7484-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-017-7484-0_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7482-6
Online ISBN: 978-94-017-7484-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)